Results from an ongoing prospective study report that a novel spinal neuromodulation device changes the paradigm for patients suffering with low back pain
who have not found relief through conventional spinal cord stimulation (SCS). The single-centered results from this ongoing, multi-centered study were presented today at the American Academy of Pain Medicine’s 27th Annual Meeting.
The results of the study were presented by Adnan Al-Kaisy MB ChB FRCA, Clinical Lead of the Pain Management & Neuromodulation Centre, Guy’s & St Thomas’ Hospital, London, UK. Dr. Al-Kaisy and his colleagues conducted the study in the United Kingdom with 30 patients (with and without previous spine surgery) who had an average back pain Visual Analog Score (VAS) of 8 (out of 10) and an average leg pain VAS score of 6 (out of ten).
- Published in Medical Breakthroughs